Obstructive sleep apnea (OSA) can affect moods and lead to chronic stress through disrupted sleep, oxygen deprivation, and ...

These sleep trackers claim to be able to detect breathing irregularities as you sleep – so how did they fare when I challenged them to sniff out my diagnosed disorder?

Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease ...

Among patients with achondroplasia, 51.6% had otitis media and 28.1% had OSA, with both conditions occurring more frequently than in patients without achondroplasia.

I am a 67-year-old male with generally good vision. I have had a few floaters in my eyes over the years, but they have ...

Launch of Inspire V system complete with strong revenue and profitability performance in the fourth quarter and FDA approval for 3.0T MRI compatibilityFourth quarter revenue growth of 12% and full ...

Inspire expects full-year earnings in the range of $1.85 to $2.35 per share, with revenue in the range of $950 million to $1 billion. This story was generated by Automated Insights ( ...

Inspire Medical Systems (INSP) came out with quarterly earnings of $1.65 per share, beating the Zacks Consensus Estimate of $0.69 per share. This compares to earnings of $1.15 per share a year ago.

Do either of these ASX 200 companies appeal to you? The post Bargain buys! – Scoop up these ASX 200 stocks after yesterday's crash appeared first on The Motley Fool Australia.

Compare Zepbound and Wegovy to understand how one hormone vs two impacts weight loss, appetite control, side effects, and ...

Asymptomatic AFib is a silent condition, so it often goes undetected until a routine physical, smart technology alert, or a medical emergency, such as a stroke or heart failure, occurs. For Black ...

Acute NAION vision worsening occurs early, often within 3 weeks, and is associated with obstructive sleep apnea and tobacco use.